Evidence map›Paper›PMID 30405985›Full record

ArticleCureus2018

Improvement of Chronic Idiopathic Urticaria With Levothyroxine: A Case Report and Review of Literature.

Amir Shahbaz, Sri Harshavardhan Senapathi, Kashif Aziz, Muhammad Umair, Amna Khalid, Issac Sachmechi

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Cureus, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Amir ShahbazInternal Medicine, Icahn School of Medicine at Mount Sinai/Queens Hospital Center, New York, USA.
Sri Harshavardhan SenapathiMedicine, Queens Hospital Center, Jamaica, USA.
Kashif AzizInternal Medicine, Icahn School of Medicine at Mount Sinai Queens Hospital Center, New York, USA.
Muhammad UmairInternal Medicine, Icahn School of Medicine at Mount Sinai Queen Hospital Center, West Hempstead, USA.
Amna KhalidInternal Medicine, Icahn School of Medicine, Mount Sinai/Queens Hospital Center, New York, USA.
Issac SachmechiInternal Medicine, Icahn School of Medicine at Mount Sinai/Queens Hospital Center, New York, USA.
Mount Sinai Hospital · USQueens Hospital Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is an increased association between chronic urticaria (CU) and thyroid autoantibodies. We presented a case of a patient suffering from CU and newly diagnosed Hashimoto's thyroiditis in which levothyroxine therapy completely resolved the symptoms of urticaria. A 58-year-old female with a past medical history of recurrent urticaria presented with complaints of fatigue and weight gain. Laboratory investigations showed a high thyroid stimulating hormone (TSH) level and a low free thyroxine (T4) level. She had elevated levels of antithyroid peroxidase (anti-TPO) and anti-thyroglobulin antibodies (anti-TG). She was diagnosed as a case of Hashimoto's thyroiditis and started on levothyroxine therapy. She noticed that her uncontrolled recurrent urticaria started to get better and after a few months of therapy, she stopped taking her topical ointments and antihistamines. The reason for the association between positive serological tests for thyroid autoimmunity and CU is unclear. The resolution of chronic urticaria with levothyroxine in our patient with Hashimoto's thyroiditis suggests a common underlying mechanism between the two pathologies.

Indexed as

chronic urticarialevothyroxinethyroid auto-antibodies

Identifiers

PMID30405985
PMCPMC6205896
OpenAlexW2888934682

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.